Announced
Completed
Synopsis
Recordati, an international pharmaceutical group, completed the acquisition of EUSA Pharma, a dynamic, global speciality pharmaceutical company, from EW Healthcare, one of the oldest and most respected healthcare growth equity firms in the world, for $849m. The transaction provides Recordati with an expanded portfolio of rare disease pharmaceutical products.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.